Esperion Therapeutics, Inc.
US ˙ NasdaqGM ˙ US29664W1053

SecurityESPR / Esperion Therapeutics, Inc.
InstitutionWolverine Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Wolverine Trading, Llc ownership in ESPR / Esperion Therapeutics, Inc.

On November 14, 2025 - Wolverine Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of Esperion Therapeutics, Inc. (US:ESPR) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 18, 2025 disclosing 10,805 shares of Esperion Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Wolverine Trading, Llc has a history of taking positions in derivatives of the underlying security (ESPR) in the form of stock options. The firm currently holds call options representing 52,700 of underlying shares valued at $139,128 USD and put options representing 16,100 of underlying shares valued at $42,504 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ESPR / Esperion Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -10,805 -100.00 0 -100.00
2025-08-18 2025-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 10,805 10,805 11 0.0000
2025-02-14 2024-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -10,969 -100.00 0 -100.00
2024-11-14 2024-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 10,969 10,969 18 0.0000
2018-11-14 2018-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -26,079 -100.00 0 -100.00
2018-08-13 2018-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 26,079 0 0.00 1,886 0.00 0.0045
2018-05-15 2018-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 26,079 16,878 183.44 1,886 211.22 0.0045
2018-02-14 2017-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 9,201 9,201 606 0.0022
2017-11-15 2017-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -11,155 -100.00 0 -100.00
2017-08-14 2017-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 11,155 11,155 527 0.0024
2016-11-14 2016-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -651 -100.00 0 -100.00
2016-08-15 2016-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 651 651 6 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F ESPERION THERAPEUTICS INC NE COM Call 52,700 109.13 139 456.00 n/a n/a n/a
2025-08-18 2025-06-30 13F ESPERION THERAPEUTICS INC NE COM Call 25,200 1.20 25 -32.43 n/a n/a n/a
2025-05-15 2025-03-31 13F ESPERION THERAPEUTICS INC NE COM Call 24,900 -17.00 37 -42.19 n/a n/a n/a
2025-02-14 2024-12-31 13F ESPERION THERAPEUTICS INC NE COM Call 30,000 62.16 64 106.45 n/a n/a n/a
2024-11-14 2024-09-30 13F ESPERION THERAPEUTICS INC NE COM Call 18,500 -35.54 31 -50.79 n/a n/a n/a
2024-08-14 2024-06-30 13F ESPERION THERAPEUTICS INC NE COM Call 28,700 64 n/a n/a n/a
2024-02-14 2023-12-31 13F ESPERION THERAPEUTICS INC NE COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-15 2023-09-30 13F ESPERION THERAPEUTICS INC NE COM Call 14,800 37.04 15 0.00 n/a n/a n/a
2023-08-23 2023-06-30 13F ESPERION THERAPEUTICS INC NE COM Call 10,800 -13.60 14 n/a n/a n/a
2023-05-15 2023-03-31 13F ESPERION THERAPEUTICS INC NE COM Call 12,500 -73.46 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F ESPERION THERAPEUTICS INC NE COM Call 47,100 293 n/a n/a n/a
2022-02-14 2021-12-31 13F ESPERION THERAPEUTICS INC NE COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-12 2021-09-30 13F ESPERION THERAPEUTICS INC NE COM Call 25,600 318 n/a n/a n/a
2021-08-06 2021-06-30 13F ESPERION THERAPEUTICS INC NE COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-14 2021-03-31 13F ESPERION THERAPEUTICS INC NE COM Call 19,200 527 n/a n/a n/a
2020-08-13 2020-06-30 13F ESPERION THERAPEUTICS INC NE COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-11 2020-03-31 13F ESPERION THERAPEUTICS INC NE COM Call 13,400 -58.77 455 -76.59 n/a n/a n/a
2020-02-12 2019-12-31 13F ESPERION THERAPEUTICS INC NE COM Call 32,500 19.49 1,944 89.11 n/a n/a n/a
2019-11-14 2019-09-30 13F ESPERION THERAPEUTICS INC NE COM Call 27,200 65.85 1,028 34.73 n/a n/a n/a
2019-08-20 2019-06-30 13F ESPERION THERAPEUTICS INC NE COM Call 16,400 12.33 763 30.20 n/a n/a n/a
2019-05-15 2019-03-31 13F ESPERION THERAPEUTICS INC NE COM Call 14,600 -28.43 586 -34.96 n/a n/a n/a
2019-02-13 2018-12-31 13F ESPERION THERAPEUTICS INC NE COM Call 20,400 901 n/a n/a n/a
2018-11-14 2018-09-30 13F ESPERION THERAPEUTICS INC NE COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-13 2018-06-30 13F ESPERION THERAPEUTICS INC NE COM Call 42,100 0.00 3,045 0.00 n/a n/a n/a
2018-05-15 2018-03-31 13F ESPERION THERAPEUTICS INC NE COM Call 42,100 28.75 3,045 41.43 n/a n/a n/a
2018-02-14 2017-12-31 13F ESPERION THERAPEUTICS INC NE COM Call 32,700 8.28 2,153 42.21 n/a n/a n/a
2017-11-15 2017-09-30 13F ESPERION THERAPEUTICS INC NE COM Call 30,200 -21.96 1,514 -17.13 n/a n/a n/a
2017-08-14 2017-06-30 13F ESPERION THERAPEUTICS INC NE COM Call 38,700 1,827 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F ESPERION THERAPEUTICS INC NE COM Put 16,100 43 n/a n/a n/a
2025-05-15 2025-03-31 13F ESPERION THERAPEUTICS INC NE COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F ESPERION THERAPEUTICS INC NE COM Put 24,600 20.00 53 52.94 n/a n/a n/a
2024-11-14 2024-09-30 13F ESPERION THERAPEUTICS INC NE COM Put 20,500 0.00 34 -24.44 n/a n/a n/a
2024-08-14 2024-06-30 13F ESPERION THERAPEUTICS INC NE COM Put 20,500 46 n/a n/a n/a
2023-05-15 2023-03-31 13F ESPERION THERAPEUTICS INC NE COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F ESPERION THERAPEUTICS INC NE COM Put 15,000 93 n/a n/a n/a
2022-02-14 2021-12-31 13F ESPERION THERAPEUTICS INC NE COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-12 2021-09-30 13F ESPERION THERAPEUTICS INC NE COM Put 11,500 143 n/a n/a n/a
2021-08-06 2021-06-30 13F ESPERION THERAPEUTICS INC NE COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-14 2021-03-31 13F ESPERION THERAPEUTICS INC NE COM Put 14,200 390 n/a n/a n/a
2020-08-13 2020-06-30 13F ESPERION THERAPEUTICS INC NE COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-11 2020-03-31 13F ESPERION THERAPEUTICS INC NE COM Put 9,800 36.11 333 -22.74 n/a n/a n/a
2020-02-12 2019-12-31 13F ESPERION THERAPEUTICS INC NE COM Put 7,200 -38.98 431 -3.36 n/a n/a n/a
2019-11-14 2019-09-30 13F ESPERION THERAPEUTICS INC NE COM Put 11,800 -28.05 446 -41.55 n/a n/a n/a
2019-08-20 2019-06-30 13F ESPERION THERAPEUTICS INC NE COM Put 16,400 -21.90 763 -9.49 n/a n/a n/a
2019-05-15 2019-03-31 13F ESPERION THERAPEUTICS INC NE COM Put 21,000 38.16 843 25.63 n/a n/a n/a
2019-02-13 2018-12-31 13F ESPERION THERAPEUTICS INC NE COM Put 15,200 671 n/a n/a n/a
2018-11-14 2018-09-30 13F ESPERION THERAPEUTICS INC NE COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-13 2018-06-30 13F ESPERION THERAPEUTICS INC NE COM Put 61,900 0.00 4,477 0.00 n/a n/a n/a
2018-05-15 2018-03-31 13F ESPERION THERAPEUTICS INC NE COM Put 61,900 538.14 4,477 600.63 n/a n/a n/a
2018-02-14 2017-12-31 13F ESPERION THERAPEUTICS INC NE COM Put 9,700 2.11 639 34.24 n/a n/a n/a
2017-11-15 2017-09-30 13F ESPERION THERAPEUTICS INC NE COM Put 9,500 23.38 476 30.77 n/a n/a n/a
2017-08-14 2017-06-30 13F ESPERION THERAPEUTICS INC NE COM Put 7,700 364 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.